Advantage Alpha Capital Partners LP Amicus Therapeutics, Inc. Transaction History
Advantage Alpha Capital Partners LP
- $337 Million
- Q2 2025
A detailed history of Advantage Alpha Capital Partners LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 35,082 shares of FOLD stock, worth $289,426. This represents 0.06% of its overall portfolio holdings.
Number of Shares
35,082Holding current value
$289,426% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding FOLD
# of Institutions
302Shares Held
332MCall Options Held
396KPut Options Held
249K-
Vanguard Group Inc Valley Forge, PA29.4MShares$243 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA29.1MShares$240 Million0.03% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$201 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY18MShares$149 Million1.88% of portfolio
-
William Blair Investment Management, LLC Chicago, IL14.6MShares$121 Million0.24% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.31B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...